Samsung humanoid program: RX division, co-design, CES 2027 target

status: watch, opened 2026-09-08, last moved 2026-09-30. Robots samsung humanoids

• The thread: Samsung's Robotics (RX) Business Promotion Office (created July 21, under DX CEO Roh Tae-moon) completed its command structure — DX CTO Yoon Jang-hyun (a software specialist) concurrently heads hardware + AI software teams, a hardware-software co-design org chart. Reported target: general-purpose humanoid prototype at CES 2027 (Samsung declined to confirm). Two tracks: internal general-purpose vs Rainbow Robotics (Samsung-controlled) industrial RB-Y2 (Robot World 2026, November).
• 2026-09-08: opened from the robots digest (feed carried MSN syndication; traced to Seoul Economic Daily Sep 7-8). Program context: Shallow-π VLA model (17 Hz, 95% sub-mm insertion in factory tests); ~₩60T (~$44.6B, approximate) group commitments incl. Gumi mass-production + AI infra; Samsung SDS orchestration platform (Sep 8, ~1,000 worksites / ~430 external cos). Strategic frame: SAG data — H1 2026 global humanoid shipments 19,100 (+272%), Chinese makers >97% (AgiBot 44%, Unitree 31%); the FCC import ban exempts Korean makers, positioning Samsung/Hyundai/LG as the non-Chinese supply chain. Cocoloop skeptic note: Samsung lacks a must-have slot for humanoids in its own ops.
• Watch for: CES 2027 demo autonomy (teleop-vs-autonomous is the tell — ledger), RB-Y2 at Robot World 2026, Samsung's scenario problem.
• 2026-09-17: a named application surface — Samsung Medical Center's humanoid surgical-assistant public demo (Sep 16, Seoul): two humanoids (scrub nurse + endoscope/traction assistant) + one surgeon on an ex-vivo/simulated procedure; first public two-humanoid+surgeon showcase. Korea's ARPA-H analog: ₩13.84B (~$10.0M approx) government R&D over 54 months through Dec 2029; ORchestra consortium — Rainbow Robotics (Samsung-controlled) builds the body, Aden Robotics the hand, SKKU/SNU the AI. Lab metrics: 100% grasp / 98.7% transfer; slower than humans (own concession). First clinical trials targeted 2029 (ledgered) — endoscopic-vision first, 4 hospitals, no legal framework yet. "World-first unified surgery" headlines oversell a staged demo — strip that framing. Program continuity with RX division; the demo culture (scoped, dated, limits stated) reads like the BD/Hyundai disclosure pattern, not the Tesla one.
• 2026-09-29: the energy layer enters the record — Samsung SDI (Hyun Jang-seok): "next year, you will be able to meet a humanoid robot powered by our 'Solid Stack' all-solid-state battery." A battery division making a dated humanoid claim — supplier-side corroboration gesture for the RX program, and the component nobody prices: energy density for household/ marathon-class autonomy. Watch: hardware demo before/with CES 2027, whether the robotics program confirms the pairing.
• 2026-09-30: the strategy layer names itself — "Reliability Over Versatility" as the commercialization pitch (syndicated; read back against the reality-check war) and the RX lab chief (Chris Hauser, Samsung AI Forum): "millions of robots could sell if users can customize them" — customization-first framing, a real differentiation against Tesla/BD hardware bets.